THE DIAGNOSTIC CHALLENGE OF RITUXIMAB-INDUCED CD20 NEGATIVE B-CELL LYMPHOMAS

被引：0
|
作者：
Risser, J. [1 ]
Breen, C. [1 ]
Feder, S. [2 ]
O'Leary, E. [1 ]
机构：
[1] Roger Williams Hosp, Providence, RI USA
[2] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
来源：
JOURNAL OF CUTANEOUS PATHOLOGY | 2011年 / 38卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [1] Modulation of CD20 expression in B-cell lymphomas treated with rituximab.
    Seliem, RM
    Freeman, JK
    Hasserjian, RP
    BLOOD, 2002, 100 (11) : 311B - 311B
  • [2] Diagnosis and treatment of CD20 negative B cell lymphomas
    Katchi, Tasleem
    Liu, Delong
    BIOMARKER RESEARCH, 2017, 5
  • [3] Diagnosis and treatment of CD20 negative B cell lymphomas
    Tasleem Katchi
    Delong Liu
    Biomarker Research, 5
  • [4] The predictive significance of CD20 expression in B-cell lymphomas
    Prevodnik, Veronika Kloboves
    Lavrencak, Jaka
    Horvat, Mateja
    Novakovic, Barbara Jezersek
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [5] The predictive significance of CD20 expression in B-cell lymphomas
    Veronika Kloboves Prevodnik
    Jaka Lavrenčak
    Mateja Horvat
    Barbara Jezeršek Novakovič
    Diagnostic Pathology, 6
  • [6] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    BLOOD, 2006, 108 (11) : 155B - 155B
  • [7] Analysis of CD20 alone could be misleading in lineage determination of B-cell lymphomas: a case of CD20 negative diffuse large B-cell lymphoma in abdominal effusion
    Hoeller, S.
    Tzankov, A.
    Feichter, G.
    Obermann, E.
    Dirnhofer, S.
    CYTOPATHOLOGY, 2009, 20 (04) : 273 - 274
  • [8] PAX5 immunostaining in the diagnosis of relapsed CD20 negative B-cell non Hodgkins lymphomas after treatment with rituximab
    Narbaitz, M. I.
    Kitagawa, R. B.
    Martin, C. A.
    HISTOPATHOLOGY, 2010, 57 : 152 - 152
  • [9] Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas
    Yi, Jun Ho
    BLOOD RESEARCH, 2021, 56 : 1 - 4
  • [10] Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab
    Takashi Sonoki
    Yaqiong Li
    Setsuko Miyanishi
    Hirokazu Nakamine
    Nobuyoshi Hanaoka
    Hiroshi Matsuoka
    Ichiro Mori
    Hideki Nakakuma
    International Journal of Hematology, 2009, 89 : 400 - 402
12345